These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2844370)

  • 1. Potential misconceptions arising from the application of enzyme kinetic equations to ligand-receptor systems at equilibrium.
    Tomlinson G
    Can J Physiol Pharmacol; 1988 Apr; 66(4):342-9. PubMed ID: 2844370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium competition binding assay: inhibition mechanism from a single dose response.
    Huang X
    J Theor Biol; 2003 Dec; 225(3):369-76. PubMed ID: 14604589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple.
    Krohn KA; Link JM
    Nucl Med Biol; 2003 Nov; 30(8):819-26. PubMed ID: 14698785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic and kinetic studies of inhibition of enzymes.
    Whiteley CG
    Cell Biochem Biophys; 2000; 33(3):217-25. PubMed ID: 11325042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An accurate method for determination of receptor-ligand and enzyme-inhibitor dissociation constants from displacement curves.
    Horovitz A; Levitzki A
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6654-8. PubMed ID: 3477796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
    Pennefather P; Quastel DM
    Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation of association curves and 'Scatchard' plots of binding reactions where ligand and receptor are degraded or internalized.
    Beck JS; Goren HJ
    J Recept Res; 1983; 3(5):561-77. PubMed ID: 6323708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A graphical method for determining inhibition constants.
    Yoshino M; Murakami K
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1288-90. PubMed ID: 19912063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new plot for multiple enzyme inhibition.
    Palatini P
    Biochem Int; 1983 Aug; 7(2):247-53. PubMed ID: 6383391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of thermodynamic allosteric parameters of an enzyme undergoing steady-state turnover.
    Reinhart GD
    Arch Biochem Biophys; 1983 Jul; 224(1):389-401. PubMed ID: 6870263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of kinetic parameters for substrate and inhibitor in a reaction with an enzyme sample containing different types of inhibitor.
    Kato T; Shimotohno K
    Biochim Biophys Acta; 1984 Sep; 801(2):157-62. PubMed ID: 6477964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic study of an enzyme-catalysed reaction in the presence of novel irreversible-type inhibitors that react with the product of enzymatic catalysis.
    Navarro-Lozano MJ; Valero E; Varon R; Garcia-Carmona F
    Bull Math Biol; 1995 Jan; 57(1):157-68. PubMed ID: 7833851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of transport inhibition by noncompetitive inhibitors.
    Krupka RM
    J Membr Biol; 1983; 74(3):175-82. PubMed ID: 6887230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of association curves and 'scatchard' plots of binding reactions where ligand and receptor are degraded or internalized.
    Beck JS; Goren HJ
    J Recept Res; 1983-1984; 3(6):745-72. PubMed ID: 6090658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of enzyme systems with suicide substrate in the presence of a reversible competitive inhibitor, tested by simulated progress curves.
    Moruno-Dávila MA; Garrido-del Solo C; García-Moreno M; Havsteen BH; Garcia-Sevilla F; Garcia-Cánovas F; Varón R
    Int J Biochem Cell Biol; 2001 Feb; 33(2):181-91. PubMed ID: 11240375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-operativity and the methods of plotting binding and steady-state kinetic data.
    Whitehead EP
    Biochem J; 1978 May; 171(2):501-4. PubMed ID: 656060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of inhibitor Ki and inhibitor type from the concentration of inhibitor for 50% inhibition for Michaelis-Menten enzymes.
    Brandt RB; Laux JE; Yates SW
    Biochem Med Metab Biol; 1987 Jun; 37(3):344-9. PubMed ID: 3606895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.
    Palatini P
    Mol Pharmacol; 1983 Jul; 24(1):30-41. PubMed ID: 6865924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of continuous over batch reactors for the kinetic analysis of enzymes inhibited by an unknown substrate impurity.
    Gallifuoco A; Alfani F; Cantarella M
    Biotechnol Bioeng; 2002 Sep; 79(6):641-6. PubMed ID: 12209811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible mechanisms of enzyme inhibition and resulting clinical significance.
    Ring B; Wrighton SA; Mohutsky M
    Methods Mol Biol; 2014; 1113():37-56. PubMed ID: 24523108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.